Exane Derivatives’s PACCAR PCAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$340K Buy
+6,200
New +$349K 0.2% 122
2017
Q2
Sell
-1,791
Closed -$80.2K 672
2017
Q1
$80.2K Sell
1,791
-644
-26% -$29K 0.02% 236
2016
Q4
$104K Buy
2,435
+728
+43% +$29.4K 0.02% 246
2016
Q3
$66.9K Buy
1,707
+645
+61% +$24.5K 0.01% 274
2016
Q2
$36.7K Buy
1,062
+150
+16% +$5.52K 0.01% 295
2016
Q1
$33.3K Hold
912
﹤0.01% 355
2015
Q4
$28.8K Sell
912
-473,102
-100% -$16.1M ﹤0.01% 278
2015
Q3
$16.5M Sell
474,014
-65,809
-12% -$2.67M 2.08% 26
2015
Q2
$23M Buy
539,823
+13,338
+3% +$576K 2.47% 14
2015
Q1
$22.2M Buy
526,485
+523,581
+18,030% +$22.2M 2.45% 9
2014
Q4
$132K Buy
+2,904
New +$125K 0.02% 258

Other funds holding PCAR

Exane Derivatives's PCAR Position: Q2 2022 in Review

Exane Derivatives opened a new position in PACCAR (PCAR) in Q2 2022: 6,200 shares worth $340K. The stake represents 0.2% of the portfolio and ranks #122 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in PCAR as recently as Q1 2017.

Exane Derivatives first reported a position in PCAR in Q4 2014 and has held it in 11 quarters since. The position peaked at $23M in Q2 2015. 703 funds tracked by Wall St. Rank hold PCAR as of Q2 2022.

  • Exane Derivatives held 6,200 shares of PACCAR worth $340K as of Q2 2022.
  • PACCAR was a new Exane Derivatives position in Q2 2022.
  • PACCAR made up 0.2% of Exane Derivatives's portfolio in Q2 2022, its #122 holding.
  • Exane Derivatives first reported a position in PACCAR in Q4 2014 and has held it in 11 quarters since.
  • Exane Derivatives's PACCAR position peaked at $23M in Q2 2015.
  • 703 funds tracked by Wall St. Rank held PACCAR as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.